FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Phosphate Injection Products
Status: Currently in Shortage
»Date first posted: 01/09/2018
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Fresenius Kabi USA, LLC (Reverified 06/17/2019)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Glycophos (sodium glycerophosphate) injection, 20 mL vial (NDC 63323-241-20) Temporary importation is available and may continue until all patient needs are met with US products. Please check wholesalers for inventory. Fresenius Kabi USA, LLC (FK USA) in conjunction with FDA has initiated temporary importation of Glycophos (sodium glycerophosphate) injection into the US market to address the ongoing shortages of phosphate injection products. Please see the Fresenius Kabi Dear Healthcare Professional Letter for additional product and supply information. FK USA is releasing Glycophos to its authorized distributors. In addition, please see the Fresenius Kabi Illustrated User Guide and Frequently Asked Questions.

Fresenius Kabi Dear Healthcare Professional Letter

Fresenius Kabi Illustrated User Guide
Frequently Asked Questions

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English